Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-11-15 Purchase | 2024-11-19 4:26 pm | TScan Therapeutics Inc. | TCRX | Lynx1 Capital Management LP Nichols Weston 10% Owner | 947 | $4.3442 | $4,114 | 5,225,547 (Indirect) | View |
| 2024-09-23 Purchase | 2024-09-24 5:26 pm | TScan Therapeutics Inc. | TCRX | Klencke Barbara Director | 5,000 | $5.29 | $26,450 | 70,000 (Indirect Direct) | View |
| 2024-08-23 Purchase | 2024-08-27 6:57 pm | TScan Therapeutics Inc. | TCRX | Klencke Barbara Director | 10,000 | $5.61 | $56,100 | 65,000 (Indirect Direct) | View |
| 2024-08-23 Sale | 2024-08-27 6:46 pm | TScan Therapeutics Inc. | TCRX | ZDRAVESKI ZORAN See Remarks | 164,686 | $5.7814 | $952,116 | 447,530 (Direct) | View |
| 2023-12-18 Purchase | 2023-12-21 5:00 pm | TScan Therapeutics Inc. | TCRX | BARBERICH TIMOTHY J Director | 29,147 | $4.8875 | $142,456 | 100,286 (Indirect Direct) | View |
| 2023-12-14 Purchase | 2023-12-18 6:01 pm | TScan Therapeutics Inc. | TCRX | Klencke Barbara Director | 5,000 | $5.08 | $25,400 | 55,000 (Indirect Direct) | View |
| 2023-06-02 Purchase | 2023-06-06 7:53 pm | TScan Therapeutics Inc. | TCRX | BARBERICH TIMOTHY J Director | 37,880 | $2.6284 | $99,564 | 71,139 (Indirect Direct) | View |
| 2023-05-31 Sale | 2023-06-02 5:35 pm | TScan Therapeutics Inc. | TCRX | Lynx1 Capital Management LP Nichols Weston 10% Owner | 25,400 | $2.5178 | $63,953 | 5,224,600 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-08-23 Exercise | 2024-08-27 6:46 pm | N/A N/A | TScan Therapeutics Inc. | TCRX | ZDRAVESKI ZORAN See Remarks | 54,895 | $4.85 | 447,530 (Direct) | View |
| 2024-08-23 Exercise | 2024-08-27 6:46 pm | N/A N/A | TScan Therapeutics Inc. | TCRX | ZDRAVESKI ZORAN See Remarks | 25,000 | $3.27 | 447,530 (Direct) | View |
| 2024-08-23 Exercise | 2024-08-27 6:46 pm | N/A 2032-01-17 | TScan Therapeutics Inc. | TCRX | ZDRAVESKI ZORAN See Remarks | 157,186 | $0 | 447,530 (Direct) | View |
| 2024-08-23 Exercise | 2024-08-27 6:46 pm | N/A N/A | TScan Therapeutics Inc. | TCRX | ZDRAVESKI ZORAN See Remarks | 13,125 | $1.81 | 447,530 (Direct) | View |
| 2024-08-23 Exercise | 2024-08-27 6:46 pm | N/A N/A | TScan Therapeutics Inc. | TCRX | ZDRAVESKI ZORAN See Remarks | 64,166 | $2.49 | 447,530 (Direct) | View |
| 2024-06-12 Option Award | 2024-06-14 4:20 pm | N/A 2034-06-11 | TScan Therapeutics Inc. | TCRX | Woods Keith Director | 47,500 | $0 | 47,500 (Direct) | View |
| 2024-06-12 Option Award | 2024-06-14 4:20 pm | N/A 2034-06-11 | TScan Therapeutics Inc. | TCRX | Dorton Katina Director | 47,500 | $0 | 47,500 (Direct) | View |
| 2024-06-12 Option Award | 2024-06-14 4:20 pm | N/A 2034-06-11 | TScan Therapeutics Inc. | TCRX | Klencke Barbara Director | 47,500 | $0 | 47,500 (Direct) | View |
| 2024-06-12 Option Award | 2024-06-14 4:20 pm | N/A 2034-06-11 | TScan Therapeutics Inc. | TCRX | Gruia Gabriela Director | 47,500 | $0 | 47,500 (Direct) | View |
| 2024-06-12 Option Award | 2024-06-14 4:20 pm | N/A 2034-06-11 | TScan Therapeutics Inc. | TCRX | Nicholson Garry A Director | 71,250 | $0 | 71,250 (Direct) | View |
| 2024-06-12 Option Award | 2024-06-14 4:13 pm | N/A 2034-06-11 | TScan Therapeutics Inc. | TCRX | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director | 95,000 | $0 | 95,000 (Indirect) | View |
| 2024-05-01 Option Award | 2024-05-03 4:05 pm | N/A 2034-04-30 | TScan Therapeutics Inc. | TCRX | Louis Chrystal Chief Medical Officer | 380,000 | $0 | 380,000 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-02 4:21 pm | N/A 2034-01-31 | TScan Therapeutics Inc. | TCRX | Amello Jason Chief Financial Officer | 750,000 | $0 | 750,000 (Direct) | View |
| 2023-12-06 Option Award | 2023-12-08 08:20 am | N/A 2033-12-05 | TScan Therapeutics Inc. | TCRX | Woods Keith Director | 17,500 | $0 | 17,500 (Direct) | View |
| 2023-07-21 Option Award | 2023-07-24 7:39 pm | N/A 2033-07-20 | TScan Therapeutics Inc. | TCRX | Dworak Leiden Chief Accounting Officer | 25,000 | $0 | 25,000 (Direct) | View |
Ownership | 2023-07-24 7:31 pm | N/A N/A | TScan Therapeutics Inc. | TCRX | Dworak Leiden Chief Accounting Officer | 0 | $0 | 235,742 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-15 6:25 pm | N/A 2033-06-12 | TScan Therapeutics Inc. | TCRX | BARBERICH TIMOTHY J Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-15 6:19 pm | N/A 2033-06-12 | TScan Therapeutics Inc. | TCRX | Barton Debora Chief Medical Officer | 430,000 | $0 | 430,000 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-15 6:17 pm | N/A 2033-06-12 | TScan Therapeutics Inc. | TCRX | Dorton Katina Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-15 6:14 pm | N/A 2033-06-12 | TScan Therapeutics Inc. | TCRX | Gruia Gabriela Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-15 6:13 pm | N/A 2033-06-12 | TScan Therapeutics Inc. | TCRX | Klencke Barbara Director | 36,524 | $0 | 36,524 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-15 6:09 pm | N/A 2033-06-12 | TScan Therapeutics Inc. | TCRX | Silver Brian M. Chief Financial Officer | 632,500 | $0 | 632,500 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-15 6:08 pm | N/A 2033-06-12 | TScan Therapeutics Inc. | TCRX | MacBeath Gavin Chief Executive Officer | 1,121,300 | $0 | 1,121,300 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-15 6:01 pm | N/A 2033-06-12 | TScan Therapeutics Inc. | TCRX | ZDRAVESKI ZORAN Chief Legal Officer | 430,000 | $0 | 430,000 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-15 4:40 pm | N/A 2033-06-13 | TScan Therapeutics Inc. | TCRX | BAKER BROS. ADVISORS LP 667 L.P. BAKER FELIX BAKER JULIAN Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP Director | 70,000 | $0 | 70,000 (Indirect) | View |
Ownership | 2023-06-05 4:09 pm | N/A N/A | TScan Therapeutics Inc. | TCRX | EcoR1 Capital LLC 10% Owner | 0 | $0 | 5,000,000 (Indirect) | View |
Ownership | 2023-06-02 5:33 pm | N/A N/A | TScan Therapeutics Inc. | TCRX | Lynx1 Capital Management LP Nichols Weston 10% Owner | 0 | $0 | 5,250,000 (Indirect) | View |
| 2023-06-01 Option Award | 2023-06-02 4:00 pm | N/A N/A | TScan Therapeutics Inc. | TCRX | BAKER BROS. ADVISORS LP 667 L.P. BAKER FELIX BAKER JULIAN Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP Director | 37,500,000 | $1.9999 | 37,500,000 (Indirect) | View |
| 2023-04-06 Option Award | 2023-04-10 10:39 am | N/A 2033-04-05 | TScan Therapeutics Inc. | TCRX | Klencke Barbara Director | 9,146 | $0 | 9,146 (Direct) | View |
Ownership | 2023-04-10 10:35 am | N/A N/A | TScan Therapeutics Inc. | TCRX | Klencke Barbara Director | 0 | $0 | 50,000 (Direct) | View |
| 2023-02-02 Option Award | 2023-02-06 5:18 pm | N/A 2033-02-01 | TScan Therapeutics Inc. | TCRX | SOUTHWELL DAVID P Chief Executive Officer | 100,000 | $0 | 100,000 (Direct) | View |